Diabetes (Insulin-requiring, Type 1 or Type 2), Skin Abnormalities
Conditions
Brief summary
This study was a cross-sectional, observational design without involving random grouping or intervention. From July 2026 to June 2027, 199 children with type 1 diabetes who had received insulin treatment for at least 6 months and their main family caregivers were recruited by a continuous enrollment method from the endocrinology department of a tertiary children's hospital in Zhejiang Province. Qualified investigators conducted on-site distribution and collection of structured questionnaires, collecting general information of the children, the occurrence of skin complications, and the insulin injection behaviors of the caregivers. At the same time, personnel with ultrasound qualifications used a wireless handheld ultrasound combined with a skin lipid caliper to uniformly measure the subcutaneous fat thickness at 8 sites including the abdomen, buttocks, arms, and thighs.
Interventions
None listed
Sponsors
The Children's Hospital of Zhejiang University School of Medicine
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Patient meets the diagnostic criteria for T1DM recommended by WHO and is diagnosed with T1DM. * Patient was diagnosed with T1DM for \>= 6 months. * Patient has no cognitive or awareness disorders and has the ability to read. * Patient agrees to participate in this study. * Patient's family caregiver has a certain level of comprehension ability, is conscious and clear-minded during the survey, and can answer freely. * Patient's family caregiver voluntarily participates in the survey. * Patient's family caregiver provides an average daily care time for the child of \>= 6 hours.
Exclusion criteria
* Patient has acute or chronic complications of diabetes and is unable to cooperate, requiring urgent treatment. * Patient is in a state of disease stress, such as acute infection, surgery, trauma, etc., and is difficult to cooperate with the research. * Patient's family caregiver has unconsciousness or abnormal mental state. * Patient's family caregiver has hearing or language disorders. * Patient or patient's family caregiver has already participated in this survey.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of insulin injection-related lipohypertrophy | 2026.07-2027.06 | The proportion of children with type 1 diabetes who are identified as having insulin injection-related lipohypertrophy. Lipohypertrophy will be determined as present if it is detected by physical examination and/or ultrasound assessment; results from these assessments will be combined into a single yes/no determination for each participant and reported as a proportion. |
Contacts
CONTACT晓春 陈, bachelor
Outcome results
None listed